Families caring for someone with Alzheimer’s disease now have a second FDA-cleared drug for agitation, and for the first time ...

Patients taking antidopaminergic agents are at risk of developing tardive dyskinesia (TD), a disorder characterized by abnormal, involuntary movements of the face, trunk, and limbs. However, women may ...

In a new systematic review and network meta-analysis, researchers compared the efficacy and acceptability of atypical antipsychotics approved by the FDA for adjunctive treatment of major depressive ...

All studied antipsychotic agents vs placebo reduced symptoms, and significant differences in tolerability were observed, underscoring the need for new clinical guidelines on individualized ...

Some nursing homes are adding inappropriate diagnoses of schizophrenia to patient charts to mask their misuse of antipsychotic drugs and inflate their CMS ratings, an Office of Inspector General ...

Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...

An Immigration and Customs Enforcement detainee was repeatedly denied his antipsychotic medication, resulting in cascading symptoms that caused him to harm himself and gouge out one of his eyes, a ...

Federal regulators are reportedly reexamining a policy discouraging use of antipsychotic medications in nursing homes unless patients have one of three specific conditions. Citing an email from the ...

The Centers for Medicare and Medicaid Services (CMS) is “actively” reviewing federal rules on antipsychotic use for residents in nursing homes, aiming to support clinically appropriate use while ...

Seventy-two years after the first antipsychotic, Thorazine, was approved, psychiatry is only now seriously discussing the need to deprescribe these drugs. For millions already exposed, that ...